Azilsartan kamedoxomil
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Drugs for hypertension.
Journal: The Medical letter on drugs and therapeutics
Published: June 20, 2020
Use of azilsartan medoxomil in the primary-care setting in Germany: A real-world evidence study .
Journal: International journal of clinical pharmacology and therapeutics
Published: March 09, 2019
Antihypertensive Efficacy of Fixed Combination Azilsartan Medoxomil / Chlorthalidone in Patients With Uncontrolled Arterial Hypertension
Journal: Kardiologiia
Published: December 26, 2017
A Rapid Novel HPLC Method for Estimation of Eight Related Compounds in Azilsartan Kamedoxomil and Identification of Degradation Compounds by Using LC-MS.
Journal: Journal of chromatographic science
Published: August 03, 2014
Azilsartan medoxomil/chlorthalidone: a new fixed-dose combination antihypertensive.
Journal: The Annals of pharmacotherapy
Published: April 16, 2013
Azilsartan, aliskiren, and combination antihypertensives utilizing renin-angiotensin-aldosterone system antagonists.
Journal: American journal of therapeutics
Published: September 15, 2012
Azilsartan medoxomil: a review of its use in hypertension.
Journal: Clinical drug investigation
Published: August 11, 2012
Azilsartan Medoxomil (Edarbi): The Eighth Angiotensin II Receptor Blocker.
Journal: P & T : a peer-reviewed journal for formulary management
Published: February 21, 2012
Azilsartan medoxomil: a new angiotensin II receptor antagonist for treatment of hypertension.
Journal: The Annals of pharmacotherapy
Published: November 26, 2011
Azilsartan medoxomil (Edarbi) the eighth ARB.
Journal: The Medical letter on drugs and therapeutics
Published: May 14, 2011
Showing 1-11 of 11
Last Updated: 02/24/2026